POP prevention project receives MRFF research grant
By Rob Clancy, staff writer
A new prevention treatment for a condition that’s been called “a hidden pandemic” has attracted significant funding in the 2025 MRFF Early to Mid-Career Researchers grant round.
Dr Hamid Bidkhori and a team of 13 chief investigators will be funded for the project “BirthHeal: Topical RNA Therapy for Early Postpartum Repair of Maternal Birth Injuries”.
The aim is to treat birth injuries early, to avoid them developing into Pelvic Organ Prolapse (POP) – a condition that affects 40 per cent of all women and 1-in-4 women who have given birth.
POP develops when tissues, pelvic floor muscles and ligaments that support the pelvic organs (bladder, uterus and bowel) become damaged, usually in childbirth, causing organs to shift or ‘drop’ into or outside the vagina. POP is essentially a hernia through which organs protrude because supporting tissue is weak.
RNA-based POP prevention
Dr Bidkhori and his team are working on a hugely promising RNA-based oligonucleotide treatment, for use soon after childbirth, in collaboration with his Hudson Institute colleagues Associate Professor Shayanti Mukherjee and Professor Michael Gantier.
The treatment is designed to reduce inflammation and support healing at the injury site, helping to prevent progression to POP.
The project has received funding of $942,332.28 over three years.
Chief Investigators
Dr Hamid Bidkhori, Hudson Institute of Medical Research
A/Prof Shayanti Mukherjee, Hudson Institute of Medical Research
Prof Michael Gantier, Hudson Institute of Medical Research
Dr Kallyanashis Paul, Hudson Institute of Medical Research|
Dr Holly Ung, Hudson Institute of Medical Research
Prof Anna Rosamilia, Monash Health
Assoc Prof Daniel Rolnik, Monash University
Dr Saeedeh Darzi, Hudson Institute of Medical Research
Dr Sunil Sapkota, Hudson Institute of Medical Research
Dr Shavi Fernando, Monash University
Prof Jerome Werkmeister, Hudson Institute of Medical Research
Dr Nirmal Bhatt, Monash University
Dr Cristina Giogha, Hudson Institute of Medical Research
Dr Paivi Karjalainen, Hospital Nova
Associate Investigators
Dr David Hennes, Monash University
Ms Amy Dawes, Birth Trauma Association
Collaborators | Monash Health, Monash University, Hospital Nova, Birth Trauma Association
This research was supported by | 2025 MRFF Early to Mid-Career Researchers grant, stream 3
In this article
-
Dr Hamid Bidkhori
Translational Tissue Engineering -
Associate Professor Shayanti Mukherjee
Translational Tissue Engineering -
Professor Michael Gantier
Nucleic Acids and Innate Immunity -
Dr Kallyanashis Paul
Translational Tissue Engineering -
Holly Ung
Translational Tissue Engineering -
Professor Anna Rosamilia AM
Translational Tissue Engineering -
Dr Saeedeh Darzi
Translational Tissue Engineering -
Dr Sunil Sapkota
Nucleic Acids and Innate Immunity -
Dr Shavi Fernando
-
Professor Jerome Werkmeister
Endometrial Stem Cell Biology -
Dr Nirmal Bhatt
Translational Tissue Engineering -
Dr Cristina Giogha
Innate Immune Responses to Infection -
Dr David Hennes
Translational Tissue Engineering
About Hudson Institute
Hudson Institute’ s research programs deliver in three areas of medical need – inflammation, cancer, women’s and newborn health. More
Hudson News
Get the inside view on discoveries and patient stories
“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”